The Ministry of Health and Prevention has signed a Memorandum of Understanding (MoU) with NewBridge Pharmaceuticals and Axios Gulf Companies, to launch an initiativefor the treatment of patients with rheumatoid who are not covered by health insurance, or a primary insurance that does not cover free treatment of this disease.
The MoU was signed at the ministry in Dubai by Dr. Amin Hussein Al Amiri, Assistant Under-Secretary for Public Policy and Licensing Sector of the UAE's Ministry of Health and Prevention, and Dr. Joseph Hanein, CEO of NewBridge Pharmaceuticals, and Dr. Anas Nofal, Regional Operations Manager at Axios Gulf.
Dr. Al Amiri said that the signing of the MoU with the two companies is a humanitarian and medical initiative that implements the strategy of the ministry to improve health services and scientific research, in accordance with the best international practices.
Source :WAM
GMT 14:01 2018 Thursday ,30 August
Expat with rare heart disorder gets life-saving surgeryGMT 00:18 2018 Tuesday ,23 January
Boy with 10-pound tumour on face diesGMT 21:23 2018 Monday ,22 January
All set for first global medical tourism conference in DubaiGMT 22:46 2018 Sunday ,21 January
Second face transplant for FrenchmanGMT 07:51 2018 Saturday ,20 January
Trio aquitted of negligence in Canada railway disasterGMT 10:57 2018 Thursday ,18 January
Breastfeeding for 6 months cuts diabetes risk in half: studyGMT 16:10 2018 Wednesday ,17 January
Child mummy in Italy had hepatitis, not smallpoxGMT 18:36 2018 Tuesday ,16 January
Greece strikes cause transport chaos, healthcare delaysMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Send your comments
Your comment as a visitor